FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕

Double triumph for cologne scientist.

Augenheilkunde, Cornea Lab Experimentelle Augenheilkunde

This year’s DOG Patent 2019 award went to Dr. Thomas Clahsen for his exceptional inventions in the area of ophthalmology. Dr. Clahsen is working at the University Hospital Cologne in the Department of Ophthalmology (Experimental Ophthalmology). This specific award is only given once a year and honors outstanding translational research and application for a patent in ophthalmology.

Dr. Thomas Clahsen is working on new Lymphangiogenesis modulators. He compared high-lymphangiogenesis C57BL/6 and low-lymphangiogenesis BALB/c mice with Quantitative Trait Locus analysis and found a new gen as a potential modulator of lymphangiogenesis. The patent describes the gen as a new useful therapeutic modulator of proliferation from lymphatic endothelial cells.

Dr. Clahsen further more was honored with the Best Paper Award for his presentation “Tyrosinase: How do pigments and angiogenesis in the eye correlate?”

Related posts

SFB 1607 Launches Website and Celebrates TEO-C New Lab Location


Read more

New SFB 1607 Launched – Building on the Foundations of FOR2240


Read more

Fakultaetspreise 2024

Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022


Read more

News

  • SFB 1607 Launches Website and Celebrates TEO-C New Lab Location
  • New SFB 1607 Launched – Building on the Foundations of FOR2240
  • Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022
  • DOG poster award for Dr. Martina Maaß
  • Young Cologne Eye Researcher Šejla Gegić won Margarete Kramer Prize

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.